Atherosclerosis

The atherogenic lipoprotein phenotype and vascular endothelial dysfunction
pp. 229-235(7)
Authors: Sattar N.; Petrie J.R.; Jaap A.J.

All low density lipoprotein particles are partially desialylated in plasma
pp. 237-245(9)
Authors: Bartlett A.L.; Stanley¹ K.K.

A role for interleukin 4 in production of matrix metalloproteinase 1 by human aortic smooth muscle cells
pp. 247-254(8)
Authors: Sasaguri T.; Arima N.; Tanimoto A.; Shimajiri S.; Hamada T.; Sasaguri Y.

Antioxidant protection of LDL by physiologic concentrations of estrogens is specific for 17-beta-estradiol
pp. 255-262(8)
Authors: Shwaery G.T.; Vita J.A.; Keaney J.F.

Monocyte superoxide production is inversely related to normal content of -tocopherol in low-density lipoprotein
pp. 263-269(7)
Authors: Cachia O.; Leger C.L.; Descomps B.

Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation
pp. 271-280(10)
Authors: Aviram M.; Rosenblat M.; Bisgaier C.L.; Newton R.S.

Colocalization of iron and ceroid in human atherosclerotic lesions
pp. 281-288(8)
Authors: Lee F.-Y.; Lee T.-S.; Pan C.-C.; Huang A.-L.; Chau L.-Y.

Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol/LDL-apo B as indices of hyperapobetalipoproteinemia and small dense LDL
pp. 289-299(11)
Authors: Hattori Y.; Suzuki M.; Tsushima M.; Yoshida M.; Tokunaga Y.; Wang Y.; Zhao D.; Takeuchi M.; Hara Y.; Ikeda Ryomoto K.; Ikebuchi M.; Kishioka H.; Mannami T.; Baba S.; Harano Y.

-VLDL accumulation in familial dysbetalipoproteinemia is associated with increased exchange or diffusion of chylomicron lipids to apo B-100 containing triglyceride-rich lipoproteins
pp. 301-312(12)
Authors: Demacker P.N.M.; Bredie S.J.H.; Vogelaar J.M.; Hectors M.P.C.; van Heijst P.; M.J. Stuyt P.; Stalenhoef A.F.H.

Cellular cholesterol synthesis-The relationship to post-prandial glucose and insulin following weight loss
pp. 313-318(6)
Authors: Griffin M.; Frazer A.; Johnson A.; Collins P.; Owens D.; Tomkin G.H.

Temporal and kinetic determinants of the inhibition of LDL oxidation by N-acetylcysteine (NAC)
pp. 319-327(9)
Authors: Rattan A.K.; Arad Y.

Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis
pp. 329-334(6)
Authors: Ormrod D.J.; Holmes C.C.; Miller T.E.

Expression of -IFN responsive genes in scavenger receptor over-expressing monocytes is associated with xanthomatosis
pp. 335-345(11)
Authors: Grewal T.; Boudreau M.; Roy M.; Chamberland A.; Lefebvre C.; Lavigne J.; Davignon J.; Minnich A.

Association of mild hyperhomocysteinemia with cardiac graft vascular disease
pp. 347-350(4)
Authors: Ambrosi P.; Garcon D.; Riberi A.; Habib G.; Barlatier A.; Kreitmann B.; Rolland P.H.; Bouvenot G.; Luccioni R.; Metras D.

Characterization of two HDL subfractions and LpA-I, LpA-I:A-II distribution profiles and clinical characteristics of hyperalphalipoproteinemic subjects without cholesterol ester transfer protein deficiency.
pp. 351-360(10)
Authors: Sich D.; Sadi Y.; Giral P.; Lagrost L.; Dallongeville J.; Federspiel M.-C.; Cherfils C.; Raisonnier A.; Turpin G.; Beucler I.

Lack of association between carotid intima-media thickness and paraoxonase gene polymorphism in non-insulin dependent diabetes mellitus
pp. 361-366(6)
Authors: Cao H.; Girard-Globa A.; Serusclat A.; Bernard S.; Bondon P.; Picard S.; Berthezene F.; Moulin P.

Genetic variation in the amino-terminal part of apolipoprotein B: studies in hyperlipidemic patients
pp. 367-374(8)
Authors: Ilmonen M.; Knudsen P.; Taskinen M.-R.; Tikkanen M.J.

Erythrocyte antioxidant status in asymptomatic hypercholesterolemic men
pp. 375-381(7)
Authors: Simon E.; Paul J.-L.; Atger V.; Simon A.; Moatti N.

Evidence against alterations in Lecithin:cholesterol acyltransferase (LCAT) activity in Familial combined hyperlipidemia
pp. 383-389(7)
Authors: Ribalta J.; La Ville A.E.; Carles Vallve J.; Girona J.; Masana L.

Myocardial infarction and percent arteriographic stenosis of culprit lesion - Report from the Program on the Surgical Control of the Hyperlipidemias (POSCH)
pp. 391-401(11)
Authors: Buchwald H.; Hunter D.W.; Tuna N.; Williams S.E.; Boen J.R.; Hansen B.J.; Titus J.L.; Campos C.T.